Timothy Keutzer

Timothy Keutzer is the current Chief Development Officer at Spero Therapeutics. Prior to joining Spero, Timothy spent 12 years at Cubist Pharmaceuticals where they served as Vice President of Program Management. In this role, Timothy was responsible for overall coordination of cross-functional activities, timelines, and budgets for Cubist's drug development efforts.

Before their time at Cubist, Timothy spent 10 years at Wyeth in various roles including preclinical research, clinical research, project management, and marketing.

Timothy has over 20 years of experience in the pharmaceutical industry and has been instrumental in the development of several successful drugs. Timothy is a highly respected leader in the field and is known for their ability to get results from cross-functional teams.

Some of their coworkers include Ian A. Critchley - VP, Clinical Microbiology, Cristina Larkin - Chief Operating Officer, and Troy Lister - VP R&D. Their manager is Ankit Mahadevia, President & CEO .